Trial · NCT07909343
Patient Needs and Preferences for NSCL Cancer Treatment Monitoring
NCT07909343, Recruiting, European Institute of Oncology
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Patient Needs and Preferences for NSCL Cancer Treatment Monitoring. Trials, record NCT07909343. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909343
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Patient Needs and Preferences for NSCL Cancer Treatment Monitoring
- NCT number
- NCT07909343
- Status
- Recruiting
- Enrollment
- 35 participants, estimated
- Lead sponsor
- European Institute of Oncology
- Conditions
- Lung Cancer (NSCLC)
- Interventions
- Focus Group Discussion
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Identification and prioritisation of attributes relevant to lung cancer treatment experience and symptom monitoring | Through study completion, up to 12 months. | Will be evaluated including the biophysical, psychological, and social impacts; patient and caregiver preferences and experiences regarding symptom monitoring; and PROs, PREMs, COAs, and quality-of-life monitoring through telemedicine and Digital Health Technologies (DHTs). The final outcome will be a prioritized set of attributes and their corresponding levels, developed through focus group discussions (FGDs) and the Nominal Group Technique (NGT), to inform the subsequent quantitative preference study. Time Frame: Through study completion, up to 12 months. |
| Secondary | Exploration of experiences, needs, preferences, treatment impact, digital monitoring, and comparison with literature/clinician input. | Through study completion, up to 12 months. | Exploration and characterization of patients' and caregivers' experiences, needs, and preferences regarding lung cancer treatment and symptom monitoring, including the biophysical, psychological, and social impacts of treatment and the use of telemedicine systems and Digital Health Technologies (DHTs) for symptom and quality-of-life monitoring. The study will also assess the consistency of the identified attributes with the existing literature and clinician input and define the levels of the selected attributes for the subsequent quantitative preference study. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909343
GET https://conductscience.org/api/trials/v1/NCT07909343/registered